Top compounds associated with response to ADAM8


Feature Type Standardized
Nominal ANOVA
mRNA tivantinib CTRPv2 pan-cancer AAC 0.0048 0.9
mRNA tivozanib CTRPv2 pan-cancer AAC -0.024 0.5
mRNA tivozanib GDSC1000 pan-cancer AAC -0.019 0.6
mRNA tosedostat CTRPv2 pan-cancer AAC 0.075 0.05
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.037 0.3
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.037 0.3
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC -0.031 0.3
mRNA trifluoperazine CTRPv2 pan-cancer AAC 0.014 0.7
mRNA triptolide CTRPv2 pan-cancer AAC 0.011 0.8
mRNA tubastatin A GDSC1000 pan-cancer AAC -0.072 0.03
Download CSV